NRGXQ Financials 07/16/2014 01:37:10 Neurologix,
Post# of 4
Posted On: 07/16/2014 2:37:07 AM
NRGXQ Financials 07/16/2014 01:37:10
Neurologix, Inc.
Period Ending Dec 31, 2010
Total Revenue -
Cost of Revenue -
Gross Profit -
Operating Expenses
Research and Development 6,035
Sales, General and Admin. 3,217
Non-Recurring Items -
Other -
Operating Income (9,252)
Income From Continuing Operations
Add'l Income/Expense Items (456)
Earnings Before Interest and Tax (9,708)
Interest Expense 455
Earnings Before Tax (10,163)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (10,163)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (10,163)
Preferred Stock and Other Adjustments (3,274)
Net Income Applicable to Common Shareholders (13,437)
Neurologix, Inc.
Period Ending Dec 31, 2010
Total Revenue -
Cost of Revenue -
Gross Profit -
Operating Expenses
Research and Development 6,035
Sales, General and Admin. 3,217
Non-Recurring Items -
Other -
Operating Income (9,252)
Income From Continuing Operations
Add'l Income/Expense Items (456)
Earnings Before Interest and Tax (9,708)
Interest Expense 455
Earnings Before Tax (10,163)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (10,163)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (10,163)
Preferred Stock and Other Adjustments (3,274)
Net Income Applicable to Common Shareholders (13,437)
(0)
(0)Neurologix Inc (NRGXQ) Stock Research Links
Scroll down for more posts ▼